LA LEGGIA, L. Multiple Sclerosis and Nabiximols at the times of COVID-19. European Journal of Case Reports in Internal Medicine, [S. l.], v. 8, n. Sup 2, 2021. DOI: 10.12890/2021_V8Sup2. DisponĂ­vel em: https://www.ejcrim.com/index.php/EJCRIM/article/view/2985. Acesso em: 16 jun. 2024.